Home › Trial NCT00243841
Dose Escalation Study for Primary Hepatocellular Carcinoma
- Trial IDNCT00243841
- StatusCompleted
- PhaseN/A
- Study typeInterventional
- SponsorIndiana University
- Enrollment77
- Start date2004-05
- ConditionsCarcinoma, Hepatocellular
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.